Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report
A 71-year-old female patient with B-cell depletion due to treatment with an anti-CD20 monoclonal antibody was admitted for worsening COVID-19. Overall, she had persistent viral shedding, worsening respiratory failure, and progressive pneumonia that did not improve despite dexamethasone and antibioti...
Enregistré dans:
Auteurs principaux: | Ayham Daher, Tobias Müller, Jens Spiesshoefer, Michael Dreher, Jens Panse |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a834fbe74cfc422ea3aa8142f10c845b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- Monoclonal antibodies in immunodiagnosis and immunotherapy
-
Histiocitosis Hemofagocítica y Aplasia Medular en Fiebre Tifoidea
par: Valdés L,Verónica, et autres
Publié: (1983) -
Aplasia medular después de un tratamiento con cloromicetina: Relato de un caso de evolución fatal
par: GARCES,HUMBERTO, et autres
Publié: (1952) -
Aplasia cutis congénita: a propósito de cuatro casos: a study of 4 cases
par: Pérez C.,Lilian, et autres
Publié: (2001) -
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
par: Abuasab T, et autres
Publié: (2021)